240 related articles for article (PubMed ID: 20952588)
1. PTP1B suppresses prolactin activation of Stat5 in breast cancer cells.
Johnson KJ; Peck AR; Liu C; Tran TH; Utama FE; Sjolund AB; Schaber JD; Witkiewicz AK; Rui H
Am J Pathol; 2010 Dec; 177(6):2971-83. PubMed ID: 20952588
[TBL] [Abstract][Full Text] [Related]
2. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
Aoki N; Matsuda T
J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of small peptide compounds, molecular docking, and inhibitory activity evaluation against phosphatases PTP1B and SHP2.
Kostrzewa T; Sahu KK; Gorska-Ponikowska M; Tuszynski JA; Kuban-Jankowska A
Drug Des Devel Ther; 2018; 12():4139-4147. PubMed ID: 30584278
[TBL] [Abstract][Full Text] [Related]
4. A nuclear protein tyrosine phosphatase TC-PTP is a potential negative regulator of the PRL-mediated signaling pathway: dephosphorylation and deactivation of signal transducer and activator of transcription 5a and 5b by TC-PTP in nucleus.
Aoki N; Matsuda T
Mol Endocrinol; 2002 Jan; 16(1):58-69. PubMed ID: 11773439
[TBL] [Abstract][Full Text] [Related]
5. Serotonin suppresses β-casein expression via PTP1B activation in human mammary epithelial cells.
Chiba T; Maeda T; Sanbe A; Kudo K
Biochem Biophys Res Commun; 2016 Apr; 473(1):323-328. PubMed ID: 27016479
[TBL] [Abstract][Full Text] [Related]
6. IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity.
Gan Y; Zhang Y; Buckels A; Paterson AJ; Jiang J; Clemens TL; Zhang ZY; Du K; Chang Y; Frank SJ
Mol Endocrinol; 2013 Nov; 27(11):1969-79. PubMed ID: 24030252
[TBL] [Abstract][Full Text] [Related]
7. Association of protein tyrosine phosphatases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing.
Kakazu A; Sharma G; Bazan HE
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2927-35. PubMed ID: 18579758
[TBL] [Abstract][Full Text] [Related]
8. Small Molecule Degraders of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase for Cancer Immunotherapy.
Dong J; Miao J; Miao Y; Qu Z; Zhang S; Zhu P; Wiede F; Jassim BA; Bai Y; Nguyen Q; Lin J; Chen L; Tiganis T; Tao WA; Zhang ZY
Angew Chem Int Ed Engl; 2023 May; 62(22):e202303818. PubMed ID: 36973833
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel, high potent, ABC type PTP1B inhibitors with TCPTP selectivity and cellular activity.
Liu P; Du Y; Song L; Shen J; Li Q
Eur J Med Chem; 2016 Aug; 118():27-33. PubMed ID: 27123900
[TBL] [Abstract][Full Text] [Related]
10. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.
Sangwan V; Paliouras GN; Abella JV; Dubé N; Monast A; Tremblay ML; Park M
J Biol Chem; 2008 Dec; 283(49):34374-83. PubMed ID: 18819921
[TBL] [Abstract][Full Text] [Related]
12. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
13. Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells.
Lee YJ; Song H; Yoon YJ; Park SJ; Kim SY; Cho Han D; Kwon BM
Biochem Pharmacol; 2020 May; 175():113920. PubMed ID: 32201212
[TBL] [Abstract][Full Text] [Related]
14. Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells.
Chughtai N; Schimchowitsch S; Lebrun JJ; Ali S
J Biol Chem; 2002 Aug; 277(34):31107-14. PubMed ID: 12060651
[TBL] [Abstract][Full Text] [Related]
15. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase-1B and T-cell protein tyrosine phosphatase regulate IGF-2-induced MCF-7 cell migration.
Blanquart C; Karouri SE; Issad T
Biochem Biophys Res Commun; 2010 Jan; 392(1):83-8. PubMed ID: 20059965
[TBL] [Abstract][Full Text] [Related]
17. Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases.
Leung KC; Brce J; Doyle N; Lee HJ; Leong GM; Sjögren K; Ho KK
Endocrinology; 2007 May; 148(5):2417-23. PubMed ID: 17272397
[TBL] [Abstract][Full Text] [Related]
18. PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
Lu X; Malumbres R; Shields B; Jiang X; Sarosiek KA; Natkunam Y; Tiganis T; Lossos IS
Blood; 2008 Nov; 112(10):4098-108. PubMed ID: 18716132
[TBL] [Abstract][Full Text] [Related]
19. Prolactin-induced PAK1 tyrosyl phosphorylation promotes FAK dephosphorylation, breast cancer cell motility, invasion and metastasis.
Hammer A; Diakonova M
BMC Cell Biol; 2016 Aug; 17(1):31. PubMed ID: 27542844
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase.
Hoyt R; Zhu W; Cerignoli F; Alonso A; Mustelin T; David M
J Immunol; 2007 Sep; 179(6):3402-6. PubMed ID: 17785772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
